Mastoid Bone Autograft for Dorsal Nasal Augmentation

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00545428

Enrollment

Registered

2007-10-17

Start date

2006-04-30

Completion date

2008-12-31

Last updated

2009-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nose Deformities, Acquired

Keywords

Nasal acquired diseases, Nasal congenital diseases, Rhinoplasty, Grafts

Brief summary

The purpose of this study is to evaluate the safety and efficacy of mastoid bone autograft for dorsal nasal augmentation in rhinoplasty.

Detailed description

INTRODUCTION: Several grafts and/or implants have been used for dorsal augmentation. In some cases, especially the traumatic, non-caucasian, and multi-operated ones, the amount of augmentation is higher than the usually available from septal and auricular conchal autografts. OBJECTIVE: To evaluate the safety and efficacy of mastoid bone autograft for dorsal nasal augmentation in rhinoplasty. DESIGN: A prospective study of 15 consecutive patients submitted to dorsal nasal augmentation with mastoid bone, during a 2-year period. SETTING: One major academic medical center.

Interventions

PROCEDURERhinoplasty

Mastoid bone autograft for dorsal nasal augmentation

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Nasal acquired or congenital deformity of the dorsum that requires augmentation of more than 5 mm

Exclusion criteria

* Previous otologic surgery/disease

Design outcomes

Primary

Measure	Time frame
Patient's satisfaction	1 year

Secondary

Measure	Time frame
Observer's satisfaction	1 year

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026